HGS TR2JAlternative Names: Anti-TRAIL R2 monoclonal antibody; HGS-TR2J; KMTR-2; TRAIL-R2 mAb
Latest Information Update: 21 Apr 2008
At a glance
- Originator Human Genome Sciences; Kirin Brewery
- Developer Human Genome Sciences
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; TRAIL receptor 2 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Solid tumours